Location History:
- Lancing, GB (2002)
- Worthing, GB (2005 - 2009)
Company Filing History:
4 out of 2,198 
3 out of 446 
1 out of 1,168 
Years Active: 2002-2009
Title: Barry Barton: Innovator in Clavams Production
Introduction
Barry Barton is a notable inventor based in Worthing, GB. With a total of five patents to his name, he has made significant contributions to the field of biotechnology, particularly in the production of clavams such as clavulanic acid. His innovative work has paved the way for advancements in pharmaceutical manufacturing processes.
Latest Patents
Among Barry Barton's latest patents are processes aimed at improving the manufacture of clavams, specifically clavulanic acid. These patents disclose novel DNA sequences and new microorganisms that are capable of producing increased amounts of clavulanic acid. His focus on enhancing the manufacturing processes highlights his commitment to innovation in the pharmaceutical industry. Additionally, he holds a patent for novel bacterial genes, microorganisms, and processes that improve the manufacture of 5R clavams, again emphasizing his expertise in this specialized area.
Career Highlights
Barry's professional journey includes significant roles at renowned companies. He has worked with SmithKline Beecham Corporation, a leader in global healthcare. Additionally, his work with The Governors of the University of Alberta underscores his connection to academic research and innovation. These experiences have not only enriched his career but have also contributed to the advancements in his field.
Collaborations
Throughout his career, Barry has teamed up with esteemed colleagues such as Susan E. Jensen and Cecilia Anders. This collaboration with fellow researchers and professionals suggests a strong network within the scientific community, which is essential for driving innovation and sharing groundbreaking ideas.
Conclusion
In summary, Barry Barton stands as a prominent figure in the invention and innovation of clavams production. His patents reflect a deep understanding of biotechnological processes, making significant strides in this crucial area of pharmaceutical manufacturing. With a career that bridges industry and academia, Barry continues to push the boundaries of what is possible within his field.